Inhibitory Antibodies
-
F2036 Anti-TGFb1 Antibody (Metelimumab)Summary: Anti-TGFb1 Antibody (Metelimumab) -
F2037 Anti-AXL/UFO Antibody (Enapotamab vedotin)Summary: Anti-AXL/UFO Antibody (Enapotamab vedotin) -
F2038 Anti-HGFR/c-Met Antibody (Telisotuzumab vedotin)Summary: Anti-HGFR/c-Met Antibody (Telisotuzumab vedotin) -
F2039 Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab-MMAE)Summary: Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab-MMAE) -
F2040 Anti-HGFR/c-Met Antibody (Onartuzumab)Summary: Anti-HGFR/c-Met Antibody (Onartuzumab) -
F2041 Anti-FGFR2/CD332 Antibody (Aprutumab)Summary: Anti-FGFR2/CD332 Antibody (Aprutumab) -
F2042 Anti-FGFR2/CD332 Antibody (Bemarituzumab)Summary: Anti-FGFR2/CD332 Antibody (Bemarituzumab) -
F2043 Anti-FGFR3/CD333 Antibody (Vofatamab)Summary: Anti-FGFR3/CD333 Antibody (Vofatamab) -
F2044 Anti-VEGFR2/KDR/CD309 Antibody (Olinvacimab)Summary: Anti-VEGFR2/KDR/CD309 Antibody (Olinvacimab) -
F2045 Anti-VEGF Antibody (Bevacizumab)Summary: Anti-VEGF Antibody (Bevacizumab)